BBOT — BRIDGEBIO ONCOLOGY THERAPEUT
Reported value held$87.93M
Funds holding (latest)23
SectorHealth Care
Funds holding (Q2 2026)21
Institutional value$77.73M · 10.50M sh
New / Add / Cut / Exit3 / 5 / 9 / 0
Top-5 / Top-10 concentration84.0% / 94.9%
Institutional holdings change
Reducing -2.5%
(-269.63K sh)
Institutional value change
Down -15.9%
As of Q2 2026, 21 SEC-registered investment managers reported holding BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) in their latest 13F filings, with a combined reported value of $77.73M across 10.50M shares. That is -2.5% by share count (-269.63K shares) versus the previous quarter, while reported value moved -15.9%. Ownership is concentrated: the five largest holders account for 84.0% of reported value and the top ten for 94.9%.
Compared with the prior quarter, 3 opened new positions, 5 added to existing stakes, 9 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BBOT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Wellington Management Group history | 2.79M | $21.25M | 0.00% | Reduce |
| Citadel Advisors history | 2.62M | $19.95M | 0.00% | Add |
| BlackRock Inc history | 2.15M | $16.41M | 0.00% | Add |
| Geode Capital Management history | 622.35K | $4.74M | 0.00% | Add |
| Royce & Associates history | 384.94K | $2.93M | 0.02% | Reduce |
| Charles Schwab Investment Management history | 286.52K | $2.18M | 0.00% | Reduce |
| Casdin Capital history | 282.31K | $2.15M | 0.11% | Hold |
| Fidelity Management & Research (FMR) history | 240.59K | $1.83M | 0.00% | Hold |
| Northern Trust Corp history | 186.48K | $1.42M | 0.00% | Add |
| UBS Group AG history | 114.66K | $873.67K | 0.00% | Add |
| Millennium Management history | 105.48K | $803.76K | 0.00% | Reduce |
| Goldman Sachs Group history | 102.08K | $777.89K | 0.00% | Reduce |
| Moore Capital Management history | 100.00K | $762.00K | 0.01% | Hold |
| Bank of America Corp history | 77.14K | $587.81K | 0.00% | New |
| Renaissance Technologies history | 58.60K | $446.53K | 0.00% | Reduce |
| Manulife Financial history | 27.98K | $213.24K | 0.00% | Reduce |
| Two Sigma Investments history | 26.48K | $201.82K | 0.00% | New |
| Citigroup Inc history | 19.87K | $151.43K | 0.00% | New |
| Morgan Stanley history | 3.38K | $25.75K | 0.00% | Reduce |
| T. Rowe Price Associates history | 300.00K | $2.29K | 0.00% | Reduce |
| Wells Fargo & Co history | 300 | $2.29K | 0.00% | Hold |
Q1 2026 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Wellington Management Group history | 2.82M | $25.22M | 0.01% | Reduce |
| Citadel Advisors history | 2.53M | $22.63M | 0.00% | Hold |
| BlackRock Inc history | 2.09M | $18.69M | 0.00% | Hold |
| Royce & Associates history | 636.52K | $5.70M | 0.06% | New |
| Geode Capital Management history | 579.23K | $5.19M | 0.00% | Add |
| Charles Schwab Investment Management history | 290.81K | $2.60M | 0.00% | Add |
| Casdin Capital history | 282.31K | $2.53M | 0.19% | Hold |
| Millennium Management history | 265.95K | $2.38M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | 240.30K | $2.15M | 0.00% | Hold |
| Goldman Sachs Group history | 167.57K | $1.50M | 0.00% | Add |
| Northern Trust Corp history | 102.26K | $915.21K | 0.00% | Add |
| Renaissance Technologies history | 101.90K | $912.00K | 0.00% | Add |
| Moore Capital Management history | 100.00K | $895.00K | 0.02% | Hold |
| UBS Group AG history | 50.45K | $451.53K | 0.00% | Reduce |
| Morgan Stanley history | 43.37K | $388.20K | 0.00% | Add |
| Manulife Financial history | 35.69K | $319.44K | 0.00% | Reduce |
| T. Rowe Price Associates history | 437.89K | $3.92K | 0.00% | Reduce |
| Wells Fargo & Co history | 300 | $2.69K | 0.00% | Hold |
Q4 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Wellington Management Group history | 2.91M | $36.40M | 0.01% | Reduce |
| Citadel Advisors history | 2.53M | $31.68M | 0.01% | Hold |
| BlackRock Inc history | 2.08M | $26.10M | 0.00% | Add |
| Vanguard Group history | 791.10K | $9.90M | 0.00% | Add |
| Geode Capital Management history | 561.99K | $7.04M | 0.00% | Add |
| Casdin Capital history | 282.31K | $3.53M | 0.22% | Hold |
| Charles Schwab Investment Management history | 279.05K | $3.49M | 0.00% | Hold |
| Millennium Management history | 241.41K | $3.02M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | 240.30K | $3.01M | 0.00% | Add |
| Moore Capital Management history | 100.00K | $1.25M | 0.02% | Hold |
| Goldman Sachs Group history | 94.65K | $1.19M | 0.00% | New |
| UBS Group AG history | 93.37K | $1.17M | 0.00% | Add |
| Renaissance Technologies history | 74.30K | $930.24K | 0.00% | New |
| Northern Trust Corp history | 58.03K | $726.59K | 0.00% | Reduce |
| Manulife Financial history | 54.19K | $670.36K | 0.00% | New |
| Point72 Asset Management history | 23.58K | $295.27K | 0.00% | New |
| Morgan Stanley history | 14.35K | $179.69K | 0.00% | Add |
| Bank of America Corp history | 3.99K | $49.95K | 0.00% | Add |
| T. Rowe Price Associates history | 803.13K | $10.06K | 0.00% | Reduce |
| Wells Fargo & Co history | 300 | $3.76K | 0.00% | New |
Q3 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Wellington Management Group history | 2.96M | $34.29M | 0.01% | New |
| Citadel Advisors history | 2.54M | $29.39M | 0.01% | New |
| BlackRock Inc history | 2.05M | $23.72M | 0.00% | New |
| Vanguard Group history | 647.60K | $7.50M | 0.00% | New |
| Geode Capital Management history | 541.60K | $6.27M | 0.00% | New |
| Millennium Management history | 369.56K | $4.06M | 0.00% | New |
| Casdin Capital history | 282.31K | $3.27M | 0.27% | New |
| Charles Schwab Investment Management history | 279.35K | $3.23M | 0.00% | New |
| Fidelity Management & Research (FMR) history | 162.08K | $1.88M | 0.00% | New |
| Moore Capital Management history | 100.00K | $1.16M | 0.02% | New |
| Northern Trust Corp history | 95.96K | $1.11M | 0.00% | New |
| UBS Group AG history | 52.23K | $604.78K | 0.00% | New |
| Bank of America Corp history | 1.33K | $15.39K | 0.00% | New |
| T. Rowe Price Associates history | 885.04K | $10.25K | 0.00% | New |
| Morgan Stanley history | 861 | $9.97K | 0.00% | New |
New Positions (Q2 2026)
- Bank of America Corp 77.14K sh · $587.81K
- Two Sigma Investments 26.48K sh · $201.82K
- Citigroup Inc 19.87K sh · $151.43K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| Wellington Management Group | 2.79M | 2.82M | 2.91M | 2.96M |
| Citadel Advisors | 2.62M | 2.53M | 2.53M | 2.54M |
| BlackRock Inc | 2.15M | 2.09M | 2.08M | 2.05M |
| Geode Capital Management | 622.35K | 579.23K | 561.99K | 541.60K |
| Royce & Associates | 384.94K | 636.52K | — | — |
| Charles Schwab Investment Management | 286.52K | 290.81K | 279.05K | 279.35K |
| Casdin Capital | 282.31K | 282.31K | 282.31K | 282.31K |
| Fidelity Management & Research (FMR) | 240.59K | 240.30K | 240.30K | 162.08K |
| Northern Trust Corp | 186.48K | 102.26K | 58.03K | 95.96K |
| UBS Group AG | 114.66K | 50.45K | 93.37K | 52.23K |
| Millennium Management | 105.48K | 265.95K | 241.41K | 369.56K |
| Goldman Sachs Group | 102.08K | 167.57K | 94.65K | — |
| Moore Capital Management | 100.00K | 100.00K | 100.00K | 100.00K |
| Bank of America Corp | 77.14K | — | 3.99K | 1.33K |
| Renaissance Technologies | 58.60K | 101.90K | 74.30K | — |
| Manulife Financial | 27.98K | 35.69K | 54.19K | — |
| Two Sigma Investments | 26.48K | — | — | — |
| Citigroup Inc | 19.87K | — | — | — |
| Morgan Stanley | 3.38K | 43.37K | 14.35K | 861 |
| T. Rowe Price Associates | 300.00K | 437.89K | 803.13K | 885.04K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details